BRCA2 and prostate carcinoma: In the joint analysis of BRCA1 and BRCA2 carriers, men in the top PRSPC quartile had a prostate cancer odds ratio of 3.35 (95% CI = 2.06 to 5.42) compared with men in the lowest quartile (Supplementary Table 7, available online).